8-K Announcements
6Material company update
Mar 11, 2026·SEC
Material company update
Mar 2, 2026·SEC
Material company update
Feb 25, 2026·SEC
LifeStance Health Group, Inc.(LFST)Earnings, Financials & Key Ratios
LFST•NASDAQ
$7.36
$2.85B mkt cap·368.0× P/E·Price updated May 6, 2026
AboutLifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.Show more
- Revenue$1.42B+13.9%
- EBITDA$80M+104.5%
- Net Income$10M+116.8%
- EPS (Diluted)0.02+113.3%
- Gross Margin28.53%-11.3%
- EBITDA Margin5.65%+79.7%
- Operating Margin1.8%+171.4%
- Net Margin0.68%+114.8%
- ROE0.65%+116.3%
- ROIC1.19%+191.2%
- Debt/Equity0.13-62.0%
- Interest Coverage2.06+275.9%
LFST Key Insights
LifeStance Health Group, Inc. (LFST) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 7/9
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 30.4%
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
LFST Price & Volume
LifeStance Health Group, Inc. (LFST) stock price & volume — 10-year historical chart
Loading chart...
LFST Growth Metrics
LifeStance Health Group, Inc. (LFST) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years30.44%
3 Years18.33%
TTM13.85%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM116.82%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM113.18%
Return on Capital
10 Years-4.26%
5 Years-7.68%
3 Years-3.34%
Last Year1.34%
LFST Recent Earnings
LifeStance Health Group, Inc. (LFST) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 5/12 qtrs (42%)
Q1 2026Latest
Feb 25, 2026EPS
$0.03
Est $0.00
Revenue
$382M
Est $378M
+1.0%
Q4 2025
Nov 6, 2025EPS
$0.00
Est $0.01
+127.7%
Revenue
$364M
Est $379M
-3.9%
Q3 2025
Aug 7, 2025EPS
$0.01
Est $0.03
+66.7%
Revenue
$345M
Est $358M
-3.6%
Q2 2025
May 7, 2025EPS
$0.00
Est $0.04
+104.6%
Revenue
$333M
Est $349M
-4.5%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 25, 2026 | $0.03vs $0.00 | $382Mvs $378M+1.0% |
| Q4 2025 | Nov 6, 2025 | $0.00vs $0.01+127.7% | $364Mvs $379M-3.9% |
| Q3 2025 | Aug 7, 2025 | $0.01vs $0.03+66.7% | $345Mvs $358M-3.6% |
| Q2 2025 | May 7, 2025 | $0.00vs $0.04+104.6% | $333Mvs $349M-4.5% |
Based on last 12 quarters of dataView full earnings history →
LFST Peer Comparison
LifeStance Health Group, Inc. (LFST) competitors in Outpatient clinics and surgery centers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ACHC | 2.33B | 25.30 | -2.08 | 5.04% | -32.84% | -40.92% | 1.24 | |
 UHS | 10.55B | 168.49 | 7.29 | 9.71% | 8.56% | 20.65% | 0.74 | |
 SGRY | 1.89B | 14.59 | -23.92 | 6.24% | -2.28% | -2.39% | 1.14 | |
 OPCH | 3.2B | 20.45 | 16.10 | 13.03% | 3.64% | 15.28% | ||
 ENSG | 10.28B | 175.93 | 30.13 | 18.72% | 6.89% | 16.61% | 1.86 | |
 TALK | 869.39M | 5.19 | 129.75 | 22% | 3.4% | 6.89% | ||
 TDOC | 1.23B | 6.80 | -5.96 | -1.54% | -6.81% | -12.37% | 0.75 | |
 AMWL | 119.11M | 7.15 | -1.20 | -1.98% | -48.16% | -33.48% | 0.02 |
Compare LFST vs Peers
LifeStance Health Group, Inc. (LFST) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
LFST Income Statement
LifeStance Health Group, Inc. (LFST) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 212.52M | 377.22M | 667.51M | 859.54M | 1.06B | 1.25B | 1.42B |
| Revenue Growth % | - | 77.5% | 76.96% | 28.77% | 22.82% | 18.5% | 13.85% |
| Cost of Goods Sold | 150.12M | 242.9M | 466M | 622.52M | 753.57M | 848.57M | 1.02B |
| COGS % of Revenue | 70.64% | 64.39% | 69.81% | 72.43% | 71.38% | 67.83% | 71.47% |
| Gross Profit | 62.4M▲ 0% | 134.32M▲ 115.3% | 201.51M▲ 50.0% | 237.02M▲ 17.6% | 302.1M▲ 27.5% | 402.4M▲ 33.2% | 406.35M▲ 1.0% |
| Gross Margin % | 29.36% | 35.61% | 30.19% | 27.57% | 28.62% | 32.17% | 28.53% |
| Gross Profit Growth % | - | 115.27% | 50.02% | 17.62% | 27.46% | 33.2% | 0.98% |
| Operating Expenses | 47.16M | 118.88M | 487.86M | 447.19M | 491.23M | 434.01M | 380.64M |
| OpEx % of Revenue | 22.19% | 31.52% | 73.09% | 52.03% | 46.53% | 34.69% | 26.72% |
| Selling, General & Admin | 41.06M | 87.84M | 433.73M | 377.99M | 410.79M | 363.06M | 382.2M |
| SG&A % of Revenue | 19.32% | 23.29% | 64.98% | 43.98% | 38.91% | 29.02% | 26.83% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - |
| Other Operating Expenses | 6.09M | 31.05M | 54.14M | 69.2M | 80.44M | 70.95M | 0 |
| Operating Income | 15.24M▲ 0% | 15.44M▲ 1.3% | -286.35M▼ 1955.1% | -210.17M▲ 26.6% | -189.13M▲ 10.0% | -31.61M▲ 83.3% | 25.71M▲ 181.3% |
| Operating Margin % | 7.17% | 4.09% | -42.9% | -24.45% | -17.92% | -2.53% | 1.8% |
| Operating Income Growth % | - | 1.28% | -1955.1% | 26.6% | 10.01% | 83.29% | 181.31% |
| EBITDA | 21.34M | 46.48M | -232.22M | -140.98M | -108.7M | 39.34M | 80.46M |
| EBITDA Margin % | 10.04% | 12.32% | -34.79% | -16.4% | -10.3% | 3.14% | 5.65% |
| EBITDA Growth % | - | 117.85% | -599.6% | 39.29% | 22.9% | 136.19% | 104.54% |
| D&A (Non-Cash Add-back) | 6.09M | 31.05M | 54.14M | 69.2M | 80.44M | 70.95M | 54.75M |
| EBIT | 15.24M | -22.28M | -294.19M | -212.8M | -185.36M | -31.08M | 24.02M |
| Net Interest Income | -5.41M | 0 | -38.91M | -19.93M | -21.22M | -26.54M | -11.66M |
| Interest Income | 0 | 22.13M | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 5.41M | 22.13M | 38.91M | 19.93M | 21.22M | 26.54M | 11.66M |
| Other Income/Expense | -7.37M | -59.85M | -46.75M | -22.56M | -17.45M | -26M | -13.34M |
| Pretax Income | 7.88M▲ 0% | -44.41M▼ 663.9% | -333.11M▼ 650.1% | -232.73M▲ 30.1% | -206.58M▲ 11.2% | -57.61M▲ 72.1% | 12.36M▲ 121.5% |
| Pretax Margin % | 3.71% | -11.77% | -49.9% | -27.08% | -19.57% | -4.61% | 0.87% |
| Income Tax | 2.21M | -6.34M | -25.91M | -17.17M | -20.32M | -170K | 2.7M |
| Effective Tax Rate % | 28.01% | 14.28% | 7.78% | 7.38% | 9.84% | 0.3% | 21.84% |
| Net Income | 5.67M▲ 0% | -38.07M▼ 771.5% | -307.2M▼ 706.9% | -215.56M▲ 29.8% | -186.26M▲ 13.6% | -57.44M▲ 69.2% | 9.66M▲ 116.8% |
| Net Margin % | 2.67% | -10.09% | -46.02% | -25.08% | -17.64% | -4.59% | 0.68% |
| Net Income Growth % | - | -771.55% | -706.93% | 29.83% | 13.59% | 69.16% | 116.82% |
| Net Income (Continuing) | 5.67M | -38.07M | -307.2M | -215.56M | -186.26M | -57.44M | 9.66M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.02▲ 0% | -0.83▼ 5560.5% | -1.05▼ 26.5% | -0.61▲ 41.9% | -0.51▲ 16.4% | -0.15▲ 70.6% | 0.02▲ 113.3% |
| EPS Growth % | - | -5560.53% | -26.51% | 41.9% | 16.39% | 70.59% | 113.33% |
| EPS (Basic) | 0.02 | -0.83 | -1.05 | -0.61 | -0.51 | -0.15 | 0.03 |
| Diluted Shares Outstanding | 373.65M | 373.65M | 327.52M | 355.28M | 367.46M | 379.15M | 391.14M |
| Basic Shares Outstanding | 373.65M | 373.65M | 327.52M | 355.28M | 367.46M | 379.15M | 386.02M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
LFST Balance Sheet
LifeStance Health Group, Inc. (LFST) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 27.43M | 76.28M | 266.52M | 233.22M | 225.73M | 312.51M | 416.2M |
| Cash & Short-Term Investments | 3.48M | 18.83M | 148.03M | 108.62M | 78.82M | 154.57M | 248.64M |
| Cash Only | 3.48M | 18.83M | 148.03M | 108.62M | 78.82M | 154.57M | 248.64M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 19.13M | 43.71M | 99.31M | 101.51M | 125.64M | 132.03M | 95.71M |
| Days Sales Outstanding | 32.86 | 42.29 | 54.3 | 43.1 | 43.44 | 38.52 | 24.53 |
| Inventory | 0 | 0 | 38.07M | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | 29.82 | - | - | - | - |
| Other Current Assets | 0 | 7.81M | -25.72M | 11M | 10.73M | 14.9M | 71.85M |
| Total Non-Current Assets | 253.35M | 1.49B | 1.66B | 1.94B | 1.88B | 1.81B | 1.79B |
| Property, Plant & Equipment | 22.43M | 59.35M | 152.24M | 393.62M | 358.93M | 313.92M | 311.3M |
| Fixed Asset Turnover | 9.48x | 6.36x | 4.38x | 2.18x | 2.94x | 3.99x | 4.58x |
| Goodwill | 214.61M | 1.1B | 1.2B | 1.27B | 1.29B | 1.29B | 1.29B |
| Intangible Assets | 14.95M | 332.8M | 300.36M | 263.29M | 221.07M | 190.8M | 177.66M |
| Long-Term Investments | 0 | -10.85M | -42.56M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.36M | 2.65M | 3.45M | 10.79M | 10.89M | 7.72M | 5.42M |
| Total Assets | 280.78M▲ 0% | 1.57B▲ 459.1% | 1.93B▲ 22.8% | 2.17B▲ 12.8% | 2.11B▼ 2.9% | 2.12B▲ 0.4% | 2.2B▲ 4.0% |
| Asset Turnover | 0.76x | 0.24x | 0.35x | 0.40x | 0.50x | 0.59x | 0.65x |
| Asset Growth % | - | 459.06% | 22.77% | 12.8% | -2.94% | 0.39% | 4.04% |
| Total Current Liabilities | 55.01M | 75.92M | 116.75M | 176M | 202.87M | 228.89M | 251.96M |
| Accounts Payable | 8.3M | 7.69M | 14.15M | 24.37M | 23.21M | 7.24M | 6.12M |
| Days Payables Outstanding | 20.17 | 11.55 | 11.08 | 14.29 | 11.24 | 3.12 | 2.2 |
| Short-Term Debt | 0 | 3.74M | 1.32M | 2.35M | 2.92M | 7.25M | 45.54M |
| Deferred Revenue (Current) | 0 | 0 | 76.06M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 23.17M | 19.25M | -50.83M | 16.47M | 8.93M | 18.98M | 200.3M |
| Current Ratio | 0.50x | 1.00x | 2.28x | 1.33x | 1.11x | 1.37x | 1.65x |
| Quick Ratio | 0.50x | 1.00x | 1.96x | 1.33x | 1.11x | 1.37x | 1.65x |
| Cash Conversion Cycle | - | - | 73.04 | - | - | - | - |
| Total Non-Current Liabilities | 392.13M | 495.97M | 265.33M | 479.15M | 478.17M | 443.13M | 430.96M |
| Long-Term Debt | 79.31M | 362.53M | 157.42M | 225.08M | 280.29M | 279.79M | 148.55M |
| Capital Lease Obligations | 0 | 0 | 0 | 212.59M | 181.36M | 148.7M | 0 |
| Deferred Tax Liabilities | 863K | 81.23M | 54.28M | 38.7M | 15.57M | 14.33M | 16.41M |
| Other Non-Current Liabilities | 311.95M | 17.21M | 53.63M | 2.78M | 952K | 309K | 266M |
| Total Liabilities | 447.13M | 571.89M | 382.08M | 655.15M | 681.04M | 672.01M | 682.92M |
| Total Debt | 79.31M | 366.27M | 158.74M | 478.83M | 511.04M | 485.19M | 194.1M |
| Net Debt | 75.83M | 347.44M | 10.71M | 370.21M | 432.22M | 330.62M | -54.55M |
| Debt / Equity | - | 0.37x | 0.10x | 0.32x | 0.36x | 0.34x | 0.13x |
| Debt / EBITDA | 3.72x | 7.88x | - | - | - | 12.33x | 2.41x |
| Net Debt / EBITDA | 3.55x | 7.47x | - | - | - | 8.40x | -0.68x |
| Interest Coverage | 2.82x | -1.01x | -7.56x | -10.68x | -8.74x | -1.17x | 2.06x |
| Total Equity | -166.35M▲ 0% | 997.84M▲ 699.8% | 1.55B▲ 54.8% | 1.52B▼ 1.7% | 1.43B▼ 5.9% | 1.45B▲ 1.2% | 1.52B▲ 5.2% |
| Equity Growth % | - | 699.82% | 54.84% | -1.7% | -5.91% | 1.21% | 5.17% |
| Book Value per Share | -0.45 | 2.67 | 4.72 | 4.27 | 3.89 | 3.81 | 3.89 |
| Total Shareholders' Equity | -166.35M | 997.84M | 1.55B | 1.52B | 1.43B | 1.45B | 1.52B |
| Common Stock | 3K | 1.01B | 3.74M | 3.76M | 3.79M | 3.83M | 3.88M |
| Retained Earnings | -166.36M | -13.13M | -357.07M | -572.64M | -760.85M | -818.29M | -808.63M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | -35M | 0 | 3.27M | 2.3M | 929K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
LFST Cash Flow Statement
LifeStance Health Group, Inc. (LFST) cash flow — operating, investing & free cash flow history
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|
| Cash from Operations | 17.05M | -8.53M | 9.42M | 52.79M | -16.88M | 107.26M | 146.15M |
| Operating CF Margin % | 8.02% | -2.26% | 1.41% | 6.14% | -1.6% | 8.57% | 10.26% |
| Operating CF Growth % | - | -150.05% | 210.39% | 460.39% | -131.98% | 735.28% | 36.26% |
| Net Income | 5.67M | -38.07M | -307.2M | -215.56M | -186.26M | -57.44M | 9.66M |
| Depreciation & Amortization | 6.09M | 31.05M | 54.14M | 69.2M | 80.44M | 70.95M | 54.75M |
| Stock-Based Compensation | 54K | 1.45M | 259.44M | 187.43M | 99.39M | 76.17M | 74.7M |
| Deferred Taxes | 1.76M | 0 | -26.95M | -16.73M | -21.92M | -958K | 2.42M |
| Other Non-Cash Items | 478K | -2.21M | 27.85M | 45.4M | 45.2M | 45.91M | 44.96M |
| Working Capital Changes | 2.99M | -753K | 2.14M | -16.94M | -33.72M | -27.37M | -40.34M |
| Change in Receivables | -5.76M | -13.3M | -24.21M | -21.66M | -24.18M | -6.4M | 36.09M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 2.54M | 829K | 623K | 7.67M | -5.61M | 501K | -1.56M |
| Cash from Investing | -73.38M | -861.17M | -194.08M | -139.46M | -60.34M | -21.57M | -36.13M |
| Capital Expenditures | -14.31M | -38.07M | -94.49M | -79.25M | -40.52M | -21.57M | -36.13M |
| CapEx % of Revenue | 6.74% | 10.09% | 14.16% | 9.22% | 3.84% | 1.72% | 2.54% |
| Acquisitions | -59.06M | -823.1M | -99.58M | -60.21M | -19.82M | 0 | 0 |
| Investments | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 48.46M | 912.27M | 313.86M | 47.26M | 47.43M | -9.95M | -15.96M |
| Debt Issued (Net) | 55.45M | 291.41M | -223.77M | 69.56M | 55.28M | -1.69M | -7.25M |
| Equity Issued (Net) | 0 | 20M | 549.9M | -904K | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -1M | 0 | -904K | 0 | 0 | 0 |
| Other Financing | -6.99M | 600.87M | -12.28M | -21.39M | -7.86M | -8.26M | -8.71M |
| Net Change in Cash | -7.86M▲ 0% | 15.35M▲ 295.2% | 129.2M▲ 741.8% | -39.41M▼ 130.5% | -29.8M▲ 24.4% | 75.75M▲ 354.2% | 94.07M▲ 24.2% |
| Free Cash Flow | 2.73M▲ 0% | -46.6M▼ 1804.4% | -85.07M▼ 82.6% | -26.47M▲ 68.9% | -57.4M▼ 116.9% | 85.69M▲ 249.3% | 110.03M▲ 28.4% |
| FCF Margin % | 1.29% | -12.35% | -12.74% | -3.08% | -5.44% | 6.85% | 7.72% |
| FCF Growth % | - | -1804.43% | -82.56% | 68.89% | -116.9% | 249.28% | 28.39% |
| FCF per Share | 0.01 | -0.12 | -0.26 | -0.07 | -0.16 | 0.23 | 0.28 |
| FCF Conversion (FCF/Net Income) | 3.01x | 0.22x | -0.03x | -0.24x | 0.09x | -1.87x | 15.12x |
| Interest Paid | 4.58M | 0 | 22.41M | 14.37M | 21.04M | 24.99M | 17.8M |
| Taxes Paid | 254K | 0 | 1.09M | 2.24M | 80K | 57K | 1.57M |
LFST Key Ratios
LifeStance Health Group, Inc. (LFST) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -9.16% | -24.16% | -14.07% | -12.64% | -4% | 0.65% |
| Return on Invested Capital (ROIC) | - | 1.85% | -14.81% | -9.15% | -7.57% | -1.3% | 1.19% |
| Gross Margin | 29.36% | 35.61% | 30.19% | 27.57% | 28.62% | 32.17% | 28.53% |
| Net Margin | 2.67% | -10.09% | -46.02% | -25.08% | -17.64% | -4.59% | 0.68% |
| Debt / Equity | - | 0.37x | 0.10x | 0.32x | 0.36x | 0.34x | 0.13x |
| Interest Coverage | 2.82x | -1.01x | -7.56x | -10.68x | -8.74x | -1.17x | 2.06x |
| FCF Conversion | 3.01x | 0.22x | -0.03x | -0.24x | 0.09x | -1.87x | 15.12x |
| Revenue Growth | - | 77.5% | 76.96% | 28.77% | 22.82% | 18.5% | 13.85% |
LFST SEC Filings & Documents
LifeStance Health Group, Inc. (LFST) SEC filings — annual & quarterly reports (10-K, 10-Q)
LFST Frequently Asked Questions
LifeStance Health Group, Inc. (LFST) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
LifeStance Health Group, Inc. (LFST) reported $1.42B in revenue for fiscal year 2025. This represents a 570% increase from $212.5M in 2019.
LifeStance Health Group, Inc. (LFST) grew revenue by 13.9% over the past year. This is steady growth.
Yes, LifeStance Health Group, Inc. (LFST) is profitable, generating $9.7M in net income for fiscal year 2025 (0.7% net margin).
Dividend & Returns
LifeStance Health Group, Inc. (LFST) has a return on equity (ROE) of 0.7%. This is below average, suggesting room for improvement.
LifeStance Health Group, Inc. (LFST) generated $146.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More LFST
LifeStance Health Group, Inc. (LFST) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates